what is glp-1 microdosing Noom expands its range with 'microdose' package Microdosing of GLP-1's / Wellness
Description
NHS Englands initial goal was to prescribe the weight loss drugs to no more than 220,000 people over three years
The purported health benefits now appear to be even more far-reaching, with the latest data from a trial called Select, published in 2023, showing that semaglutide can slash the risk of heart attacks and strokes by a fifth in patients with an existing history of cardiovascular disease
9 Rubino DMGreenway FLKhalid U STEP 8 JAMA 2022;327:138-50
Timing and injection technique also matter
often far lower than what is used during active weight loss
Some providers recommend semaglutide with methylcobalamin specifically to address the energy and neurological support needs during treatment
